Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ikaros Transcription Factor | 19 | 2021 | 26 | 2.610 |
Why?
|
B-Lymphocytes | 5 | 2021 | 329 | 1.570 |
Why?
|
Lymphopoiesis | 6 | 2016 | 16 | 1.540 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 | 2021 | 70 | 1.420 |
Why?
|
Myeloid Cells | 4 | 2015 | 57 | 1.110 |
Why?
|
Heterografts | 2 | 2017 | 70 | 1.090 |
Why?
|
Genes, Tumor Suppressor | 5 | 2021 | 61 | 1.040 |
Why?
|
Hematopoietic Stem Cells | 8 | 2015 | 268 | 0.940 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 5 | 2021 | 11 | 0.930 |
Why?
|
Casein Kinase II | 9 | 2021 | 11 | 0.910 |
Why?
|
Receptors, Cytokine | 4 | 2021 | 19 | 0.900 |
Why?
|
Interleukin-7 | 2 | 2016 | 18 | 0.880 |
Why?
|
Leukemia | 4 | 2017 | 117 | 0.880 |
Why?
|
Cytokines | 4 | 2020 | 866 | 0.880 |
Why?
|
Gene Expression Regulation, Leukemic | 9 | 2021 | 29 | 0.810 |
Why?
|
Fetal Blood | 7 | 2018 | 131 | 0.780 |
Why?
|
STAT5 Transcription Factor | 2 | 2017 | 18 | 0.720 |
Why?
|
Precursor Cells, B-Lymphoid | 2 | 2016 | 3 | 0.670 |
Why?
|
Signal Transduction | 12 | 2021 | 2689 | 0.640 |
Why?
|
Stromal Cells | 2 | 2017 | 113 | 0.640 |
Why?
|
Leukemia, T-Cell | 3 | 2014 | 21 | 0.570 |
Why?
|
Mice | 22 | 2020 | 8474 | 0.560 |
Why?
|
Gene Regulatory Networks | 1 | 2017 | 94 | 0.550 |
Why?
|
Receptors, Interleukin-7 | 1 | 2016 | 9 | 0.550 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 304 | 0.530 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2017 | 245 | 0.520 |
Why?
|
Tumor Necrosis Factor Ligand Superfamily Member 13 | 1 | 2015 | 4 | 0.510 |
Why?
|
Animals | 29 | 2020 | 20881 | 0.500 |
Why?
|
Precision Medicine | 1 | 2016 | 111 | 0.490 |
Why?
|
Cell Lineage | 6 | 2015 | 146 | 0.480 |
Why?
|
CD24 Antigen | 1 | 2014 | 6 | 0.470 |
Why?
|
Antigens, CD19 | 1 | 2014 | 17 | 0.470 |
Why?
|
Receptors, Complement 3d | 1 | 2014 | 45 | 0.460 |
Why?
|
Cytosol | 1 | 2013 | 123 | 0.450 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 157 | 0.450 |
Why?
|
Cervical Ripening | 1 | 2012 | 2 | 0.430 |
Why?
|
Parturition | 1 | 2012 | 15 | 0.430 |
Why?
|
Cervix Uteri | 1 | 2012 | 64 | 0.420 |
Why?
|
Macrophage Activation | 1 | 2012 | 75 | 0.420 |
Why?
|
Phosphoproteins | 1 | 2013 | 202 | 0.410 |
Why?
|
Cell Cycle Proteins | 2 | 2013 | 230 | 0.410 |
Why?
|
Humans | 50 | 2021 | 68618 | 0.400 |
Why?
|
RNA-Binding Proteins | 1 | 2013 | 215 | 0.400 |
Why?
|
Cell Proliferation | 3 | 2019 | 1174 | 0.390 |
Why?
|
Cell Differentiation | 12 | 2019 | 1034 | 0.390 |
Why?
|
Neutrophils | 2 | 2021 | 204 | 0.330 |
Why?
|
Cell Line | 8 | 2021 | 1752 | 0.310 |
Why?
|
Transcription Factors | 4 | 2013 | 753 | 0.300 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2021 | 118 | 0.300 |
Why?
|
Epigenesis, Genetic | 3 | 2019 | 163 | 0.300 |
Why?
|
bcl-X Protein | 2 | 2020 | 36 | 0.290 |
Why?
|
Dendritic Cells | 3 | 2017 | 201 | 0.290 |
Why?
|
Cells, Cultured | 11 | 2017 | 2673 | 0.290 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2013 | 86 | 0.290 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2020 | 332 | 0.270 |
Why?
|
Interleukin-1beta | 2 | 2017 | 88 | 0.260 |
Why?
|
Toll-Like Receptor 4 | 2 | 2017 | 114 | 0.260 |
Why?
|
Bone Marrow | 2 | 2020 | 168 | 0.250 |
Why?
|
Gene Expression Profiling | 4 | 2016 | 498 | 0.240 |
Why?
|
Palmitic Acid | 2 | 2017 | 51 | 0.230 |
Why?
|
Neoplasm Proteins | 3 | 2020 | 307 | 0.230 |
Why?
|
Repressor Proteins | 2 | 2015 | 183 | 0.230 |
Why?
|
Blood Cells | 2 | 2013 | 27 | 0.220 |
Why?
|
Mice, Transgenic | 2 | 2016 | 1033 | 0.220 |
Why?
|
Antineoplastic Agents | 3 | 2021 | 1070 | 0.220 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2013 | 11 | 0.210 |
Why?
|
Genetic Vectors | 4 | 2017 | 312 | 0.210 |
Why?
|
Gene Deletion | 2 | 2021 | 235 | 0.210 |
Why?
|
Protein Phosphatase 1 | 2 | 2014 | 36 | 0.200 |
Why?
|
Extracellular Traps | 1 | 2021 | 9 | 0.190 |
Why?
|
Blood Platelets | 2 | 2021 | 284 | 0.190 |
Why?
|
Cholera Toxin | 2 | 2011 | 30 | 0.190 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2015 | 710 | 0.190 |
Why?
|
Translocation, Genetic | 1 | 2021 | 74 | 0.180 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2021 | 72 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2017 | 223 | 0.180 |
Why?
|
Leukemia, Myelomonocytic, Acute | 1 | 2020 | 3 | 0.180 |
Why?
|
Antigens, CD34 | 4 | 2013 | 75 | 0.180 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2017 | 64 | 0.170 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 132 | 0.170 |
Why?
|
Models, Biological | 3 | 2016 | 981 | 0.170 |
Why?
|
Transduction, Genetic | 2 | 2017 | 81 | 0.170 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 84 | 0.170 |
Why?
|
Hyaluronan Receptors | 1 | 2020 | 142 | 0.170 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 63 | 0.160 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2018 | 1 | 0.160 |
Why?
|
Centromere | 2 | 2009 | 15 | 0.160 |
Why?
|
Transcription, Genetic | 2 | 2015 | 562 | 0.160 |
Why?
|
Medication Reconciliation | 1 | 2018 | 18 | 0.160 |
Why?
|
Community Pharmacy Services | 1 | 2018 | 11 | 0.160 |
Why?
|
Transcriptome | 1 | 2020 | 164 | 0.160 |
Why?
|
Leptin | 1 | 2018 | 80 | 0.150 |
Why?
|
Thymocytes | 2 | 2014 | 11 | 0.150 |
Why?
|
Health Status Disparities | 1 | 2021 | 326 | 0.150 |
Why?
|
Injections, Intraperitoneal | 1 | 2017 | 89 | 0.150 |
Why?
|
Phosphorylation | 7 | 2017 | 1200 | 0.140 |
Why?
|
Interleukin-7 Receptor alpha Subunit | 1 | 2016 | 4 | 0.140 |
Why?
|
Cell Adhesion | 2 | 2020 | 324 | 0.140 |
Why?
|
Gene Rearrangement | 1 | 2016 | 19 | 0.140 |
Why?
|
Infant, Premature | 1 | 2018 | 284 | 0.140 |
Why?
|
Transcriptional Activation | 1 | 2017 | 226 | 0.140 |
Why?
|
Coronary Artery Bypass | 3 | 2007 | 218 | 0.130 |
Why?
|
Gene Expression | 2 | 2016 | 770 | 0.130 |
Why?
|
Gestational Age | 2 | 2018 | 389 | 0.130 |
Why?
|
Janus Kinase 1 | 1 | 2015 | 3 | 0.130 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 6 | 0.130 |
Why?
|
Patient Discharge | 1 | 2018 | 294 | 0.130 |
Why?
|
Ribosomal Protein S6 Kinases | 1 | 2015 | 17 | 0.130 |
Why?
|
Lymphocyte Count | 1 | 2015 | 53 | 0.130 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 116 | 0.130 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2015 | 1 | 0.130 |
Why?
|
Histone Deacetylase 1 | 1 | 2015 | 32 | 0.130 |
Why?
|
Transgenes | 1 | 2015 | 92 | 0.130 |
Why?
|
Transplantation, Heterologous | 1 | 2015 | 122 | 0.130 |
Why?
|
Flow Cytometry | 3 | 2018 | 489 | 0.130 |
Why?
|
Point Mutation | 2 | 2013 | 97 | 0.130 |
Why?
|
Immunologic Factors | 2 | 2017 | 87 | 0.130 |
Why?
|
Gene Expression Regulation | 3 | 2019 | 1293 | 0.130 |
Why?
|
Carcinogenesis | 1 | 2016 | 124 | 0.120 |
Why?
|
DNA Nucleotidylexotransferase | 1 | 2014 | 5 | 0.120 |
Why?
|
Cardiopulmonary Bypass | 3 | 2007 | 250 | 0.120 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2015 | 282 | 0.120 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 124 | 0.120 |
Why?
|
Oncogene Proteins, Viral | 1 | 2014 | 21 | 0.120 |
Why?
|
Human papillomavirus 16 | 1 | 2014 | 23 | 0.120 |
Why?
|
Monocytes | 1 | 2015 | 210 | 0.120 |
Why?
|
Nuclear Proteins | 1 | 2015 | 271 | 0.120 |
Why?
|
Female | 11 | 2021 | 38074 | 0.110 |
Why?
|
Species Specificity | 1 | 2014 | 303 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2015 | 331 | 0.110 |
Why?
|
Lipopolysaccharides | 1 | 2015 | 455 | 0.110 |
Why?
|
Coculture Techniques | 2 | 2013 | 147 | 0.110 |
Why?
|
DNA Damage | 1 | 2014 | 190 | 0.110 |
Why?
|
Prognosis | 4 | 2021 | 2093 | 0.110 |
Why?
|
Mice, Inbred C3H | 1 | 2012 | 134 | 0.110 |
Why?
|
Enzyme Induction | 1 | 2012 | 119 | 0.110 |
Why?
|
Proteins | 1 | 2016 | 474 | 0.110 |
Why?
|
Vitamin D | 1 | 2017 | 516 | 0.100 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 189 | 0.100 |
Why?
|
Middle Aged | 7 | 2018 | 21147 | 0.100 |
Why?
|
Infant, Newborn | 2 | 2018 | 2455 | 0.100 |
Why?
|
Emergency Service, Hospital | 1 | 2018 | 711 | 0.100 |
Why?
|
Cell Count | 1 | 2012 | 248 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2015 | 626 | 0.100 |
Why?
|
DNA-Binding Proteins | 3 | 2006 | 700 | 0.100 |
Why?
|
Leukemia, B-Cell | 1 | 2011 | 7 | 0.100 |
Why?
|
SOXB1 Transcription Factors | 1 | 2011 | 20 | 0.100 |
Why?
|
S Phase | 1 | 2011 | 38 | 0.100 |
Why?
|
Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2011 | 1 | 0.100 |
Why?
|
Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2011 | 1 | 0.100 |
Why?
|
Glutamate Decarboxylase | 1 | 2011 | 18 | 0.100 |
Why?
|
RNA, Messenger | 4 | 2015 | 1664 | 0.100 |
Why?
|
Bone Marrow Cells | 3 | 2016 | 217 | 0.100 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 1851 | 0.100 |
Why?
|
Male | 9 | 2021 | 37321 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2014 | 194 | 0.100 |
Why?
|
Obesity | 1 | 2018 | 1076 | 0.090 |
Why?
|
Matrix Metalloproteinases | 1 | 2012 | 223 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2011 | 23 | 0.090 |
Why?
|
Proinsulin | 1 | 2010 | 3 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2011 | 114 | 0.090 |
Why?
|
Schwann Cells | 1 | 2010 | 33 | 0.090 |
Why?
|
Diabetic Neuropathies | 1 | 2010 | 33 | 0.090 |
Why?
|
Protein Isoforms | 3 | 2011 | 246 | 0.090 |
Why?
|
Hyperlipidemias | 1 | 2010 | 90 | 0.090 |
Why?
|
Mice, Inbred NOD | 3 | 2015 | 138 | 0.090 |
Why?
|
Autoantigens | 1 | 2010 | 91 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2014 | 718 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2019 | 597 | 0.080 |
Why?
|
Severity of Illness Index | 1 | 2015 | 1851 | 0.080 |
Why?
|
Adult | 5 | 2016 | 21403 | 0.080 |
Why?
|
Extracellular Matrix | 1 | 2012 | 493 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 1 | 2010 | 376 | 0.080 |
Why?
|
Aged | 6 | 2018 | 14862 | 0.080 |
Why?
|
Hyperglycemia | 1 | 2010 | 158 | 0.080 |
Why?
|
Macrophages | 1 | 2012 | 647 | 0.080 |
Why?
|
Lentivirus | 3 | 2013 | 35 | 0.080 |
Why?
|
Heterochromatin | 1 | 2008 | 4 | 0.080 |
Why?
|
Disease Models, Animal | 1 | 2015 | 2550 | 0.080 |
Why?
|
Up-Regulation | 1 | 2010 | 682 | 0.080 |
Why?
|
Cell Nucleus | 1 | 2009 | 305 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 507 | 0.070 |
Why?
|
Granulocytes | 1 | 2007 | 22 | 0.070 |
Why?
|
Receptors, Retinoic Acid | 1 | 2007 | 48 | 0.070 |
Why?
|
Cyclins | 1 | 2007 | 50 | 0.070 |
Why?
|
Isoxazoles | 1 | 2007 | 22 | 0.070 |
Why?
|
Endothelin A Receptor Antagonists | 1 | 2007 | 22 | 0.070 |
Why?
|
Promoter Regions, Genetic | 3 | 2016 | 615 | 0.070 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2007 | 60 | 0.070 |
Why?
|
Thiophenes | 1 | 2007 | 76 | 0.070 |
Why?
|
Pregnancy | 1 | 2012 | 2334 | 0.070 |
Why?
|
Mice, Inbred C57BL | 3 | 2015 | 2791 | 0.070 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 514 | 0.070 |
Why?
|
Cardiovascular Agents | 1 | 2007 | 82 | 0.070 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 852 | 0.070 |
Why?
|
Biomarkers, Tumor | 2 | 2021 | 508 | 0.060 |
Why?
|
Cell Separation | 2 | 2020 | 132 | 0.060 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2015 | 209 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2007 | 597 | 0.060 |
Why?
|
Endothelin-1 | 1 | 2005 | 122 | 0.060 |
Why?
|
Endothelins | 1 | 2004 | 57 | 0.060 |
Why?
|
Blood Pressure | 2 | 2007 | 1451 | 0.060 |
Why?
|
Antigens, CD | 2 | 2017 | 230 | 0.060 |
Why?
|
Reactive Oxygen Species | 2 | 2017 | 499 | 0.050 |
Why?
|
Cellular Reprogramming | 2 | 2013 | 22 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2003 | 30 | 0.050 |
Why?
|
Coronary Disease | 1 | 2005 | 358 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 1 | 2005 | 411 | 0.050 |
Why?
|
Lymphocytes | 1 | 2003 | 228 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2018 | 652 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2019 | 1692 | 0.050 |
Why?
|
Platelet Activation | 1 | 2021 | 24 | 0.050 |
Why?
|
Phenazines | 1 | 2021 | 2 | 0.050 |
Why?
|
Binding Sites | 2 | 2017 | 631 | 0.050 |
Why?
|
Naphthyridines | 1 | 2021 | 20 | 0.050 |
Why?
|
Porphyromonas gingivalis | 1 | 2021 | 33 | 0.050 |
Why?
|
Protein Binding | 3 | 2009 | 1027 | 0.050 |
Why?
|
Angiogenic Proteins | 1 | 2020 | 5 | 0.050 |
Why?
|
PAX5 Transcription Factor | 1 | 2020 | 9 | 0.040 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2020 | 37 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2020 | 82 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2021 | 326 | 0.040 |
Why?
|
Child | 2 | 2021 | 6405 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 146 | 0.040 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2019 | 43 | 0.040 |
Why?
|
Doxorubicin | 1 | 2020 | 231 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 1745 | 0.040 |
Why?
|
Genomics | 1 | 2020 | 168 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2018 | 6 | 0.040 |
Why?
|
P-Selectin | 1 | 2018 | 16 | 0.040 |
Why?
|
Myocardium | 1 | 2005 | 1204 | 0.040 |
Why?
|
Adenosine Diphosphate | 1 | 2018 | 66 | 0.040 |
Why?
|
Ohio | 1 | 2018 | 64 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2017 | 7029 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2019 | 320 | 0.040 |
Why?
|
Antigens, CD1 | 1 | 2017 | 3 | 0.040 |
Why?
|
Lymphocyte Antigen 96 | 1 | 2017 | 10 | 0.040 |
Why?
|
B7-2 Antigen | 1 | 2017 | 23 | 0.040 |
Why?
|
Caspase 1 | 1 | 2017 | 22 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2017 | 85 | 0.040 |
Why?
|
Urban Population | 1 | 2018 | 255 | 0.040 |
Why?
|
Hypercalcemia | 1 | 2017 | 34 | 0.040 |
Why?
|
Molecular Docking Simulation | 1 | 2017 | 78 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2017 | 97 | 0.040 |
Why?
|
HeLa Cells | 1 | 2017 | 237 | 0.030 |
Why?
|
Incidence | 1 | 2021 | 1603 | 0.030 |
Why?
|
Thymus Gland | 2 | 2008 | 97 | 0.030 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2017 | 137 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 108 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2018 | 483 | 0.030 |
Why?
|
Sequence Deletion | 1 | 2016 | 89 | 0.030 |
Why?
|
Chromatin | 1 | 2016 | 76 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2004 | 1615 | 0.030 |
Why?
|
U937 Cells | 1 | 2015 | 61 | 0.030 |
Why?
|
DNA | 2 | 2009 | 597 | 0.030 |
Why?
|
Lymphocyte Depletion | 1 | 2015 | 34 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 29 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2016 | 349 | 0.030 |
Why?
|
Postoperative Period | 2 | 2007 | 238 | 0.030 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2015 | 52 | 0.030 |
Why?
|
Survival Analysis | 1 | 2017 | 714 | 0.030 |
Why?
|
Prospective Studies | 2 | 2018 | 3705 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2017 | 742 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2016 | 216 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 214 | 0.030 |
Why?
|
NF-kappa B | 1 | 2017 | 432 | 0.030 |
Why?
|
Adoptive Transfer | 1 | 2015 | 100 | 0.030 |
Why?
|
Medication Adherence | 1 | 2018 | 335 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 4 | 0.030 |
Why?
|
Sex Factors | 1 | 2018 | 1266 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2017 | 370 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 434 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2021 | 3259 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 468 | 0.030 |
Why?
|
Age Factors | 1 | 2018 | 1864 | 0.030 |
Why?
|
Cell Dedifferentiation | 1 | 2013 | 4 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2013 | 25 | 0.030 |
Why?
|
Teratoma | 1 | 2013 | 22 | 0.030 |
Why?
|
Pulmonary Artery | 2 | 2007 | 323 | 0.030 |
Why?
|
Exome | 1 | 2013 | 20 | 0.030 |
Why?
|
Regenerative Medicine | 1 | 2013 | 17 | 0.030 |
Why?
|
Karyotyping | 1 | 2013 | 74 | 0.030 |
Why?
|
Connective Tissue | 1 | 2013 | 61 | 0.030 |
Why?
|
Genomic Instability | 1 | 2013 | 41 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2013 | 159 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 848 | 0.030 |
Why?
|
Mice, SCID | 1 | 2013 | 238 | 0.030 |
Why?
|
Hospitalization | 1 | 2018 | 978 | 0.030 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 63 | 0.030 |
Why?
|
Plasmids | 1 | 2013 | 258 | 0.030 |
Why?
|
Bone and Bones | 1 | 2013 | 145 | 0.030 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 659 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 756 | 0.030 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2011 | 25 | 0.020 |
Why?
|
Lymphocyte Subsets | 1 | 2011 | 16 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2011 | 95 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2011 | 90 | 0.020 |
Why?
|
Gene Order | 1 | 2010 | 13 | 0.020 |
Why?
|
Toll-Like Receptor 2 | 1 | 2010 | 34 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 194 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2010 | 144 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 329 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2009 | 77 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 90 | 0.020 |
Why?
|
United States | 1 | 2021 | 7367 | 0.020 |
Why?
|
Apoptosis | 1 | 2015 | 1641 | 0.020 |
Why?
|
Ubiquitin | 1 | 2009 | 74 | 0.020 |
Why?
|
Cyclin H | 1 | 2007 | 1 | 0.020 |
Why?
|
Retinoic Acid Receptor alpha | 1 | 2007 | 9 | 0.020 |
Why?
|
Aldehyde Oxidoreductases | 1 | 2007 | 10 | 0.020 |
Why?
|
Retinal Dehydrogenase | 1 | 2007 | 10 | 0.020 |
Why?
|
Aldehyde Dehydrogenase | 1 | 2007 | 18 | 0.020 |
Why?
|
G1 Phase | 1 | 2007 | 42 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2007 | 78 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 235 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 139 | 0.020 |
Why?
|
Amino Acids | 1 | 2008 | 131 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2007 | 50 | 0.020 |
Why?
|
Aldehyde Dehydrogenase, Mitochondrial | 1 | 2007 | 21 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 2007 | 75 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 97 | 0.020 |
Why?
|
Tretinoin | 1 | 2007 | 92 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2007 | 179 | 0.020 |
Why?
|
Time Factors | 2 | 2005 | 4655 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2008 | 1083 | 0.020 |
Why?
|
T-Cell Acute Lymphocytic Leukemia Protein 1 | 1 | 2005 | 1 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2007 | 328 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2008 | 1447 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2005 | 110 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2007 | 284 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 5717 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2005 | 58 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2006 | 397 | 0.020 |
Why?
|
Microdialysis | 1 | 2005 | 147 | 0.020 |
Why?
|
Models, Molecular | 1 | 2006 | 546 | 0.020 |
Why?
|
Hematologic Tests | 1 | 2004 | 24 | 0.010 |
Why?
|
Electrolytes | 1 | 2004 | 47 | 0.010 |
Why?
|
Adolescent | 1 | 2016 | 8912 | 0.010 |
Why?
|
Down-Regulation | 1 | 2005 | 447 | 0.010 |
Why?
|
Stem Cells | 1 | 2005 | 248 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2005 | 383 | 0.010 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2005 | 277 | 0.010 |
Why?
|
Length of Stay | 1 | 2004 | 780 | 0.010 |
Why?
|